Oklahoma City, Oklahoma 73104


The purpose of this study is to determine/identify what mechanisms/factors are involved with regard to AV nodal reentrant tachycardia.

Study summary:

HYPOTHESES: 1. The Tendon of Todaro forms a line of block during slow/fast AVNRT preventing the atrial impulse from entering the triangle of Koch (and perhaps providing sufficient time for activation to pass through the coronary sinus coat to activate the posterior extensions of the AV node as is critical to maintenance of tachycardia) 2. The coronary sinus myocardial coat participates in all of the forms of AVNRT. The reentrant circuit is thus not confined within the triangle of Koch and sites remote from the compact AV node could be targeted for ablation reducing the risk of AV conduction block. 3. A model of the reentrant circuit can be created for each patient's tachycardia, using the site of earliest retrograde activation to suggest the retrograde limb and the resetting response to suggest the anterograde limb. DATA ANALYSIS/STATISTICS: Resetting and Mapping of AV nodal reentrant tachycardia: Pacing will be analyzed to see at which sites, the tachycardia can be reset by the latest extra-stimuli (i.e., with the least advancement in local activation). The coupling interval will be compared to the latest extra-stimulus capable of resetting (advancing) the tachycardia from the postero-septal tricuspid annulus. Ablation Results: The patients will act as their own reference, since the standard ablation technique in the postero-septal space is being performed first and tested for efficacy. The McNemar test will be applied to compare the efficacy of ablation at the postero-septal tricuspid annulus alone (standard ablation), with the efficacy of this ablation plus ablation within the coronary sinus. From our initial observations, It is anticipated that the additional ablation in the coronary sinus will increase the efficacy of the procedure from <95% to >98%, such that 100 cases should provide sufficient data to reach statistical significance.


Inclusion Criteria: - Ages 16-80 - At least one documented episode of AV nodal reentrant tachycardia - Patient scheduled for electrophysiology study and catheter ablation for supraventricular tachycardia Exclusion Criteria: - Ages < 16 or > 80 - Medical condition significantly increasing risk of extending procedure time or X-ray exposure - Pregnancy - Prior ablation with radiation exposure >2 hours - Electrophysiology study performed without sedation or anesthesia - Unavailable for follow-up



Primary Contact:

Principal Investigator
Deborah Lockwood, M.D.
University of Oklahoma

Deborah Lockwood, M.D.
Phone: 405-271 9696 ext. 37531
Email: deborah-lockwood@ouhsc.edu

Backup Contact:

Email: karrie-meeks@ouhsc.edu
Karrie Meeks, BS ESE, CCRP
Phone: 405-271-9696 ext. 37520

Location Contact:

Oklahoma City, Oklahoma 73104
United States

Karrie Meeks, BS ESE, CCRP
Phone: 405-271-9696
Email: karrie-meeks@ouhsc.edu

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.